QA: Ardelyx INC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001437402_2020_Ardelyx_INC.pdf

Logs

Graph

Absolute values for 0001437402, Ardelyx INC

  xvar xval
0 AssetsCurrent 252,062,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,436,000
3 remainder_Assets 4,284,000
4 LiabilitiesCurrent 22,220,000
5 LiabilitiesNoncurrent 2,076,000
6 remainder_Liabilities 48,831,000
7 CostOfGoodsAndServicesSold 553,396
8 SellingGeneralAndAdministrativeExpense 25,504,227
9 ResearchAndDevelopmentExpense 71,796,846
10 remainder_Expenses 8,144,988
11 remainder_Revenues 4,250,202
12 remainder_NetIncome 1,829,115
13 remainder_ComprehensiveNetIncome 37,422
  yvar yval
0 Assets 259,782,000
1 Liabilities 73,127,000
2 Expenses 105,999,457
3 Revenues 4,250,202
4 StockholdersEquity 186,655,000
5 NetIncome -99,920,140
6 ComprehensiveNetIncome -99,901,429
7 BaseVar 222,512,598
8 EconomicCapitalRatiobeforeLimitedLiability 1.84
9 EconomicCapitalRatio 2.92

Edgar->Model Mapping

Feature Distribution

Change over Time